Killela Mary, Turner Cindy A, Chevrier Amy, Stefanou Monique, Vaca Lopez Perla L, Kaddas Heydon K, van Thiel Berghuijs Karely M, Warner Echo L, Perez Giselle K, Waters Austin R, Fair Douglas B, Nelson Richard E, Lewis Mark A, Park Elyse R, Kirchhoff Anne C
Cancer Control & Population Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
College of Nursing, University of Utah, Salt Lake City, UT, USA.
Prev Oncol Epidemiol. 2025;3(1). doi: 10.1080/28322134.2025.2455706. Epub 2025 Feb 6.
Health insurance education could mitigate financial toxicity experienced by young adult (YA) cancer survivors by increasing confidence when navigating cancer care costs. This paper describes the protocol in a randomized controlled trial (RCT) to test a virtual patient navigation program designed to help YA cancer survivors understand their health insurance.
This is a two-arm, multi-site (Huntsman Cancer Institute, Intermountain Health) RCT wherein intervention participants receive four sessions with a patient navigator (PN) and a booklet on insurance; usual care receives the booklet. We will enroll 300 YA cancer survivors (n=200 intervention; n=100 usual care) diagnosed with breast, testicular, lymphoma, sarcoma, colorectal, melanoma, or thyroid cancer between the ages of 26 and 39, who have completed treatment in the past two years. All participants will complete three surveys: enrollment, 6 months, and 12 months; medical records/insurance claims data will be collected out to 18-month follow-up. Recruitment began in the fall of 2023 and is expected to last approximately 2.5 years. The primary efficacy outcomes include improvement in health insurance literacy and financial toxicity at 6 months. Secondary outcomes include adherence to cancer surveillance guidelines at 18 months. We will also conduct cost-effectiveness and budget impact analyses.
Anticipated results from this trial could identify key information that YA cancer survivors need to improve health insurance literacy and survivorship care.
健康保险教育可以通过增强年轻成年癌症幸存者应对癌症治疗费用时的信心，来减轻他们所经历的经济毒性。本文描述了一项随机对照试验（RCT）的方案，以测试一个旨在帮助年轻成年癌症幸存者了解其健康保险的虚拟患者导航项目。
这是一项双臂、多中心（亨茨曼癌症研究所、山间医疗集团）的随机对照试验，其中干预组参与者接受与患者导航员（PN）的四次课程以及一本关于保险的手册；常规护理组仅收到该手册。我们将招募300名年龄在26至39岁之间、在过去两年内完成治疗、被诊断患有乳腺癌、睾丸癌、淋巴瘤、肉瘤、结直肠癌、黑色素瘤或甲状腺癌的年轻成年癌症幸存者（n = 200干预组；n = 100常规护理组）。所有参与者将完成三项调查：入组时、6个月时和12个月时；医疗记录/保险理赔数据将收集至18个月的随访期。招募工作于2023年秋季开始，预计持续约2.5年。主要疗效指标包括6个月时健康保险素养的提高和经济毒性的减轻。次要指标包括18个月时对癌症监测指南的依从性。我们还将进行成本效益和预算影响分析。
该试验的预期结果可能会确定年轻成年癌症幸存者提高健康保险素养和生存护理所需的关键信息。
